The UK’s promotion watchdog is probing a selling of Nurofen Express, after receiving complaints about a radio advert.
The Advertising Standards Authority (ASA) is examining if a advert is dubious by claiming it targets a source of headaches.
On Monday, Nurofen’s builder Reckitt Benckiser shielded their packaging, after an Australian justice systematic certain products off shelves.
The justice pronounced it had misled consumers.
Australia’s justice pronounced Nurofen’s products marketed to provide specific pains, such as migraine, were matching to one another, and pronounced that products contingency be taken off Australian shelves within 3 months.
On Monday, Nurofen shielded itself by observant that a products had been “designed to assistance a consumer simply navigate a range”, quite in groceries where there was no pharmacy.
The advert in question claims that “most headaches are caused by stretched conduct muscles”, and that a painkiller targets these muscles.
The ASA perceived 12 complaints about a advert in Feb and launched a review in March.
It said: “Complainants have challenged either a ad is dubious since it implies that a product directly targets muscles in a head. They’ve also challenged either a explain ‘gives we faster headache service than customary paracetamol or ibuprofen’ is misleading.”
The ASA stressed that it investigates selling of products, not a product itself.
“The products are regulated by health regulators such as a Medicines Healthcare products Regulatory Agency (MHRA),” a ASA added.